Pancreatic cancer: Trial drug MRK003 shows promise 2
Doctors want to improve the prognosis of this aggressive cancer and scientists say they may have found a new weapon against pancreatic cancer after promising early trial results of an experimental drug combination. Giving the chemotherapy agent gemcitabine with an experimental drug called MRK003 sets off a chain of events […]